🧬Congratulating Dr. Sam Beck on his recent grant award!

Dr. Beck has received funding from the Korean Ministry of SMEs and Startups (Global Cooperative R&D Program) for a three-year collaborative project with MabTics Co., Ltd.  They will use AI-driven protein design to develop a dual-target (Tie2/C5a) bispecific antibody therapeutic for vasculitis, computationally designing and optimizing antibody sequences.